Oracle is a global leader in AI, delivering the cloud infrastructure, data, and applications that organizations across the world trust to successfully achieve business outcomes at scale.
Oracle Cloud Infrastructure (OCI) provides fast, flexible, scalable AI infrastructure. With superior compute performance and network design, a comprehensive choice of AI services for developing and orchestrating agentic AI workflows at scale, and unrivaled data control, security, privacy, and governance, OCI is designed for AI workloads. It also gives customers the flexibility to run their workloads wherever they need by supporting public cloud, multicloud, hybrid cloud, sovereign, and on-premises deployments.
The Oracle AI Database is the only database with AI natively built in everywhere. By bringing AI to where data lives, the Oracle AI Database delivers enterprise-grade AI securely, cost-effectively, and at scale. In-database machine learning and vector search enable AI models to run where data resides. Support for multi-modal data (structured, unstructured, graph, vector) enables richer AI use cases.
The Oracle AI Data Platform enables organizations to build, deploy, and govern AI agents and applications on top of private, secure, and distributed enterprise data. This enables organizations to operationalize AI without compromising data security or control.
Oracle Applications embed AI directly into business workflows and industry processes to ensure AI is delivered in context, where work happens. They include the only applications suite that brings AI to every aspect of a business, with AI-powered ERP, HCM, and CX applications, and the Oracle Health Suite which provides applications for managing the entire healthcare ecosystem. Oracle also provides industry-specific cloud application suites for more than two dozen industries and NetSuite, the world’s first cloud computing company.
This LinkedIn page serves as Oracle’s official global company page.
Quest Diagnostics (NYSE: DGX) empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
The company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staff of about 900 M.D.s & Ph.D.s.
Quest Diagnostics offers the most extensive clinical testing network in the U.S., with laboratories in most major metropolitan areas, & in Mexico, the UK & India. The company also operates four esoteric laboratories, 40 outpatient AP laboratories, & 160 smaller, rapid-response laboratories.
Patients may have specimens collected in any of the company’s approximately 2,250 patient service centers. On a typical workday, testing is performed for about 550,000 patients.
The company is the leading provider of pre-employment drugs-of-abuse screening for employers & risk assessment services for the life insurance industry. It is the world’s 2nd largest provider of clinical trials testing for new pharmaceuticals.
More information is available at www.questdiagnostics.com. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.
Language Assistance / Non-Discrimination Notice
Asistencia de Idiomas / Aviso de no Discriminación
語言協助 / 不歧視通知
www.QuestDiagnostics.com/home/nondiscrimination
Veeva delivers the industry cloud for life sciences with software, AI, data, and business consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world’s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Correspondence to new applicants and existing candidates will only come from an official @veeva.com email address.